Health care

Little is known about the effects of e-cigarettes on users’ health. Niel Daniels, Mark Paulson and IFoA working party members examine the implications for life and health insurance.

After consecutive decades of improvement, longevity is stalling. Matthew Edwards looks atthe factors involved.

In the third instalment of our Routes to the Top series, more senior executives speak with Bradley Shearer about the paths their careers have taken, and offer advice on how to progress in our own professional lives.

Lisanne Gitsels and Elena Kulinskaya quantify the impact of statins on longevity

Howard Kearns introduces LE01: a measure of longevity risk that puts it in context with other risks and mitigating factors over time.

With obesity rates showing no signs of declining, Nay Wynn examines their effects on health, and how actuaries can factor this in when underwriting life insurance policies.

Rachael Docking explains how factors throughout life can compound to make later life challenging, and points to how such inequalities might be tackled

Petra Wildemann explores how to manage the risks of epidemics – from zoonotic diseases to human infections

Kateryna Katyukha Swiegers considers recent advances in human genome editing and what these could mean for insurers and wider society

Jackie Li and Leonie Tickle discuss recent research results on measuring basis risk and hedge effectiveness in longevity risk transfer for pension plans